Introduction of Restricted Stock Compensation
First written in FY2020-Q2. 2 of 3 entries say "Advanced", first in FY2021-Q2. Latest entry: FY2022.
- FY2022AdvancedAnnual report
「To strengthen the link between compensation and medium-term enhancement of corporate value, the stock compensation will take the form of restricted stock. It will be paid separately from the compensation framework described above but within the compensation framework approved at the Annual General Meeting of Shareholders held on 29 June 2019, with the Company issuing or disposing of common shares in exchange for monetary claims paid under this plan. From the standpoint of enhancing corporate value over the medium term, the restriction period for the restricted stock will generally be 3 years.」
The restricted stock compensation plan specifies the linkage to corporate value, payment through the issuance or disposal of shares, and a standard restriction period of 3 years. - FY2021-Q2AdvancedAnnual report
「21 August 2020 (Note) 110,390 23,305,543 9,714 2,495,740 9,603 734,225 (Note) This resulted from the issuance of new shares as restricted stock compensation. Issue price: ¥175 Amount credited to capital: ¥88 Allotment recipients: A total of 17 directors, Audit & Supervisory Board members and executive officers of the Company」
The Company issued 110,390 shares as restricted stock compensation and allotted them to a total of 17 directors, Audit & Supervisory Board members and executive officers. This was a specific implementation following the previous issuance to 16 recipients. - FY2020-Q2First statedAnnual report
「1 July 2019–30 September 2019 (Note) 68,713 23,195,153 8,039 2,486,025 8,039 724,621 (Note) This resulted from the issuance of new shares as restricted stock compensation. Issue price: ¥234 Amount credited to capital: ¥117 Allotment recipients: A total of 16 directors, Audit & Supervisory Board members and executive officers of the Company」
The Company issued 68,713 new shares as restricted stock compensation, allotting them to a total of 16 directors, Audit & Supervisory Board members and executive officers. As a result, stated capital and capital surplus each increased by ¥8.039 million.